Medpace Holdings Inc vs Magna International Inc. Common Stock — how do they compare? Medpace Holdings Inc trades at $611.57 (market cap $16.82B), while Magna International Inc. Common Stock trades at $63.99 (market cap $17.04B). The key difference: Medpace Holdings Inc and Magna International Inc. Common Stock are close in size by market cap, and Magna International Inc. Common Stock pays a 3.1% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and Magna International Inc. Common Stock for 1 Days on average.
| MEDP | MGA | |
|---|---|---|
Market Cap | $16.82B | $17.04B |
Volume | 223,093 | 1,523,784 |
Sector | Health | Consumer Cyclical |
52-Week High | $630.19 | $73.05 |
52-Week Low | $393.42 | $43.54 |
Typical Hold Time | 14 Days | 1 Days |
Enterprise Value | $16.44B | $22.08B |
Dividend Yield | — | 3.1% |
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $612.05, up 1.29% today, near its consensus price target of $620.44. The stock shows strong profitability with a 17.67% net margin and has beaten earnings estimates for the last three quarters. Technical indicators are neutral overall, with support at $595 and resistance at $612. Recent news highlights CEO stock sales and institutional position changes, while the company prepares to report Q3 2026 results on October 21.
Outlook remains positive given consistent earnings beats and projected revenue growth to $2.8B in 2026. Risks include high valuation multiples (P/E 35.41) and insider selling. Analyst consensus is cautious with 79% hold ratings, suggesting limited near-term upside but solid fundamental support for long-term holders.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →Magna International Inc. is a Canada-based automotive supplier that designs, engineers, and manufactures vehicle systems and components, including body and chassis structures, seating, powertrain, and electronics, and provides complete-vehicle engineering and contract assembly, with manufacturing operations in 28 countries.
Read more on MGA →